Analyst firm CFRA raised its price target for Globe Life from $118.00 to $130.00, maintaining a Hold rating, due to the company's robust fourth-quarter earnings which exceeded both CFRA's and consensus estimates. TD Cowen reiterated a Buy rating with a price target of $168.00, citing Globe Life's positive business trends and strong capital position. The firm noted that Globe Life's management is optimistic about future growth, supported by an increase in agent count and sales trends. Additionally, Globe Life's management is exploring the establishment of a Bermuda captive as a strategic move to enhance its long-term capital. These developments indicate Globe Life's continued focus on strengthening its financial health and growth potential. This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.